Structural basis for regulation of Frizzled-4 signaling by the co-receptor Tetraspanin-12

This study determines the 3.4-angstrom cryo-EM structure of the FZD4-Tspan12 complex, revealing how Tspan12 facilitates FZD4 trafficking and enhances Norrin binding to amplify Wnt signaling, thereby providing a molecular basis for targeting retinal vascular diseases.

The Gist

The Big Picture: Fixing the Eye's "Plumbing"

Imagine your eye is a high-tech city that needs a constant supply of fresh water (blood) to keep the lights on (vision). If the pipes don't grow correctly, the city goes dark, leading to blindness. This is what happens in a group of eye diseases like FEVR (Familial Exudative Vitreoretinopathy).

To build these pipes, the body uses a specific construction crew. The main foreman is a protein called Norrin. He needs two key workers to get the job done:

1. FZD4: The main receptor (the "door" on the cell surface).
2. LRP5/6: The co-receptor (the "key" that unlocks the door).

For years, scientists knew Norrin needed FZD4 and LRP5/6 to work. But they discovered a third, mysterious character named Tspan12. Without Tspan12, the construction crew is weak and the pipes don't grow. But how Tspan12 helps was a complete mystery. Is it a tool? A manager? A distraction?

This paper solves that mystery by taking a 3D "photograph" (using a powerful microscope called Cryo-EM) of Tspan12 and FZD4 holding hands.

---

The Key Discoveries

1. The "Hand-Holding" Discovery

The Old Theory: Scientists thought Tspan12 was like a bouncer at a club. They believed Tspan12 would grab Norrin, bring him to the door (FZD4), and then let go so Norrin could talk to the door alone. This is called a "hand-off."

The New Reality: The 3D photo shows that Tspan12 and FZD4 are actually best friends who never let go. They form a tight, permanent complex before Norrin even arrives. They are a single unit.

• The Analogy: Imagine FZD4 is a door. Tspan12 isn't a bouncer who opens the door and leaves; it's more like a doorframe that is permanently attached to the door. You can't have the door without the frame, and they work together as one piece of furniture.

2. The "Velcro" Effect

Why do they need to be attached? The paper shows that Tspan12 acts like a super-strong piece of Velcro.

• How it works: Norrin tries to stick to the door (FZD4). Sometimes, the door is a bit wobbly, and Norrin might slip off. But because Tspan12 is attached right next to the door, it grabs Norrin with its own special "hands" (called the C-D helices).
• The Result: Now, Norrin is being held by two things at once (the door and the frame). This makes the grip much stronger. It allows the construction crew to work even when there is very little Norrin around. It turns a weak signal into a strong one.

3. The "Delivery Truck" Problem

One of the strangest findings is about how Tspan12 gets to the surface of the cell. Usually, tetraspanins (the family Tspan12 belongs to) act like delivery trucks that bring other proteins to the surface.

• The Twist: In this case, it's the reverse. FZD4 is the delivery truck, and Tspan12 is the package. If FZD4 isn't there, Tspan12 gets stuck in the "warehouse" (inside the cell) and never makes it to the surface to do its job.
• The Analogy: Think of Tspan12 as a very shy person who is afraid to go to a party. FZD4 is the confident friend who grabs Tspan12 by the hand and drags them out to the dance floor. Once they are out there, they work together perfectly.

4. The "Team Huddle"

The paper also proves that Tspan12 doesn't leave the team after Norrin arrives.

• The Old Idea: Maybe Tspan12 brings Norrin to the door, then leaves so the "Key" (LRP5/6) can come in.

• The New Proof: The team (Tspan12 + FZD4 + Norrin) stays together, and then the "Key" (LRP5/6) joins the huddle. Tspan12 stays right there, acting as a core member of the signaling team.

• The Analogy: Imagine a relay race. The old idea was that Tspan12 runs the first leg, drops the baton, and goes home. The new idea is that Tspan12 runs the first leg, grabs the baton, and runs the whole race holding hands with FZD4 and LRP5/6, ensuring the message gets delivered without dropping it.

---

Why Does This Matter?

This discovery is a game-changer for treating eye diseases.

1. Understanding the Disease: We now know that if Tspan12 is broken, the "doorframe" is missing, and the construction crew can't build the blood vessels in the eye. This explains why patients with Tspan12 mutations go blind.
2. New Medicines: Because Tspan12 is only found in specific places (like the eye and ear) and not everywhere in the body, it is a perfect target for new drugs.
   • If a patient has too few blood vessels (hypo-vascularization), doctors could design drugs to help Tspan12 grab Norrin better, boosting the signal to grow more vessels.
   • If a patient has too many blood vessels (like in diabetic retinopathy), doctors could design drugs to block Tspan12, stopping the signal and preventing dangerous growth.

Summary

Think of Tspan12 not as a temporary helper, but as the essential foundation of the signaling machine. It locks onto the receptor (FZD4), drags it to the surface, and then acts as a second set of hands to grab the signal (Norrin) tightly. This ensures the message gets through loud and clear, keeping our eyes healthy and our vision sharp.

Technical Summary

1. The Problem

The Wnt/β-catenin signaling pathway is critical for development and tissue homeostasis. While Wnt ligands bind promiscuously to various Frizzled (FZD) receptors, the atypical ligand Norrin specifically activates Frizzled-4 (FZD4) to drive retinal angiogenesis. A unique feature of Norrin signaling is its absolute dependence on the tetraspanin Tspan12 for signal amplification. Mutations in NOR1, FZD4, LRP5/6, or TSPAN12 cause Familial Exudative Vitreoretinopathy (FEVR), a severe ocular disorder characterized by retinal hypo-vascularization.

Despite knowing that Tspan12 acts as a co-receptor, the molecular mechanism remained unclear. Key questions included:

• Does Tspan12 interact directly with FZD4, and if so, how?
• Does Tspan12 allosterically activate FZD4?
• Does Tspan12 function via a "hand-off" mechanism (capturing Norrin and passing it to FZD4/LRP5/6) or does it remain part of the active signaling complex?
• How does Tspan12 enhance Norrin binding affinity?

2. Methodology

The authors employed a multidisciplinary approach combining structural biology, protein engineering, and cell-based assays:

• Protein Engineering & Expression:
  • To overcome the weak affinity between Tspan12 and FZD4, they engineered a tethered fusion construct (FZD4-linker-Tspan12) to stabilize the complex.
  • To facilitate cryo-EM structure determination of the small complex (~93 kDa), they inserted a thermostabilized BRIL domain into the intracellular loop 3 (ICL3) of FZD4.
  • They utilized AlphaFold3 to design rigid linkers for the BRIL insertion and to guide initial model building.
• Cryo-Electron Microscopy (Cryo-EM):
  • The FZD4-BRIL-Tspan12 complex was purified and stabilized with an anti-BRIL Fab and an anti-Fab nanobody.
  • Single-particle cryo-EM was performed, yielding a 3.4 Å resolution structure of the complex.
• Cell-Based Functional Assays:
  • Flow Cytometry: Used to assess Tspan12 surface trafficking and measure Norrin binding affinity ($EC_{50}$) using tethered constructs and point mutants (e.g., E170K in Tspan12 Helix D).
  • Chimeric Constructs: Swapped domains (TM2, TM3, Hinge, ECL1) between FZD4 and FZD10 to map interaction interfaces required for trafficking and signaling.
  • TOPFlash Reporter Assays: Measured $\beta$-catenin signaling activity in $\Delta$FZD1–10 knockout cells to test the functional impact of tethering and domain swaps.
  • BRET (Bioluminescence Resonance Energy Transfer): Used to monitor the proximity of Tspan12 and FZD4 in live cells before and after Norrin stimulation to test the "hand-off" hypothesis.
  • Co-immunoprecipitation: Validated physical association between Tspan12 and FZD4 in the presence of Norrin.

3. Key Contributions & Results

A. Structural Insights: The FZD4-Tspan12 Complex

• Direct Interaction: The 3.4 Å structure reveals that FZD4 and Tspan12 form a direct, stable complex in the absence of Norrin.
• Transmembrane Interface: Tspan12 packs against TM2 and TM3 of FZD4 via hydrophobic interactions. This interface is crucial for the trafficking of Tspan12 to the cell surface. Mutating FZD4 TM2 to FZD10 sequence abolishes Tspan12 surface expression, indicating FZD4 acts as a chaperone for Tspan12 (a reversal of the typical tetraspanin role).
• Extracellular Interface: The Large Extracellular Loop (LEL) of Tspan12 interacts with the lower hinge domain of FZD4. This interaction is specific to FZD4 (not FZD10) and likely dictates receptor specificity.
• Conformation: Tspan12 adopts an "open" conformation (tightly packed four-helix bundle) when bound to FZD4. Crucially, the C-D helices of Tspan12 (the known Norrin binding site) remain exposed and dynamic, not occluded by FZD4.
• No Allosteric Activation: The structure shows FZD4 remains in an inactive conformation (RMSD 0.68 Å compared to inactive crystal structures). Tspan12 does not induce the conformational changes typically associated with GPCR activation (e.g., TM6 outward movement), suggesting it does not allosterically activate FZD4.

B. Mechanism of Norrin Binding Enhancement

• Avidity Effect: Because the C-D helices of Tspan12 are exposed in the complex, Norrin can bind simultaneously to the FZD4 CRD and the Tspan12 C-D helices.
• Affinity Data: Flow cytometry binding assays showed the tethered FZD4-Tspan12 complex binds Norrin with ~3-fold higher affinity ($EC_{50}$ 3.3 nM) compared to FZD4 alone ($EC_{50}$ 9.2 nM).
• Mutation Validation: An E170K mutation in the Tspan12 D-helix (predicted to disrupt Norrin binding) reduced affinity by 2-fold, confirming the C-D helices mediate Norrin capture within the complex.

C. Dynamics of the Signaling Complex

• Rejection of the "Hand-Off" Model: Previous models suggested Tspan12 captures Norrin and then dissociates to allow LRP5/6 binding.
  • BRET Assays: Norrin treatment did not decrease the BRET signal between FZD4 and Tspan12; in fact, proximity slightly increased or remained constant over 55 minutes.
  • Tethering Assay: Forcing Tspan12 to remain covalently attached to FZD4 did not inhibit signaling; the tethered complex signaled as effectively as the co-transfected (non-tethered) complex.
  • Co-IP: Tspan12 remained associated with FZD4 after Norrin stimulation.
• Conclusion: Tspan12 is a constitutive component of the active Norrin-FZD4-LRP5/6 signaling complex.

D. Proposed Model for Complex Assembly

The authors propose that Norrin (a homodimer) binds to the FZD4-Tspan12 complex via a two-site mechanism:

1. One Norrin protomer binds FZD4 (via CRD) and Tspan12 (via C-D helices).
2. The second Norrin protomer recruits LRP5/6.
   This arrangement allows Tspan12 and LRP5/6 to bind distinct protomers of the Norrin dimer without steric clash, stabilizing the entire signaling complex.

4. Significance

• Mechanistic Clarity: This study provides the first high-resolution structural basis for how a tetraspanin (Tspan12) directly regulates a GPCR (FZD4) and enhances ligand binding. It challenges the view of tetraspanins solely as "molecular facilitators" for trafficking, showing they are active signaling components.
• Therapeutic Implications:
  • FEVR and Angiogenesis: Understanding the FZD4-Tspan12 interface offers new targets for treating FEVR (hypo-vascularization) and diabetic retinopathy (hyper-vascularization).
  • Specificity: Since Tspan12 has more restricted expression than FZD4 or LRP5/6, targeting the Tspan12-Norrin interface or the Tspan12-FZD4 complex could modulate retinal angiogenesis with fewer off-target effects compared to broad Wnt pathway inhibitors.
  • Drug Design: Antibodies or small molecules that block the Norrin-binding C-D helices of Tspan12 could inhibit pathological angiogenesis, while stabilizing agents could treat hypo-vascularization.

In summary, the paper demonstrates that Tspan12 is not a transient chaperone but a permanent, structural co-receptor that increases Norrin affinity through avidity and remains integral to the active signaling complex, offering a new paradigm for tetraspanin-mediated signaling regulation.